Dr Reddy’s receives ‘positive’ opinion for Rituximab biosimilar from EMA’s CHMP
The European Commission will review the Committee for Medicinal Products for Human Use’s positive opinion to decide on granting marketing authorization in the European Union and the European Economic Area, including Norway, Iceland, and Liechtenstein.